Outstanding Poster Award at ECVIM-CA 2025 for our work on drug resistance in canine leishmaniosis
The Nano1Health team attended the ECVIM-CA 2025 Congress, the annual meeting of the European College of Veterinary Internal Medicine – Companion Animals, held in Maastricht in September 2025.
Marina Carrasco-Martín spoke about the current status of circulating genetic drug resistance in dogs with leishmaniosis. Together with Clàudia Viñeta, she presented the poster “Clinical application of genomic drug-resistance biomarkers detection in canine leishmaniosis”, which received the Outstanding ECVIM-CA 2025 Poster Award.
The congress left one key takeaway: progress in managing canine leishmaniosis, especially in relapsing cases, needs veterinarians and researchers working together. That is the bridge Nano1Health builds, from the genomics of Leishmania infantum to tests that help veterinarians choose the right treatment.
Questions about this news? Write to info@nano1health.com.